Altimmune (ALT) Prices $225 Million Offering at $3 Per Share

Altimmune (ALT) announced a public offering valued at $225 million, pricing shares at $3 each. This move is significant as it reflects the company's efforts to raise capital, likely for further development or operations. The offering could influence market perception and investor interest regarding ALT's future prospects. The company's ability to successfully execute this offering may also impact stock liquidity and overall valuation.

Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.